Results per Page:
Oncology Insights with Dr. Petros Grivas - Episode 16
Dr. Marco Mielcarek on making blood and marrow transplants safer and more accessible
Mail-in immune monitoring brings clinical trials closer to home
From the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium
Oncology Insights with Dr. Petros Grivas - Episode 15
Exploring neuro-oncology leadership and innovation with Dr. Vyshak Venur
Strengthening cancer care by building trust and community
10th annual Pathways to Health Symposium highlights projects, best practices for expanding care throughout Washington state
ASCO Young Investigator Award winners showcase the breadth and depth of Fred Hutch research
Hematology-oncology fellows and faculty receive $50,000 each toward early-career projects
Oncology Insights with Dr. Petros Grivas - Episode 14
Dr. Sara Hurvitz on clinical trials, multidisciplinary care and leadership in oncology
Fred Hutch researchers receive Prostate Cancer Foundation Young Investigator Awards
Three-year projects explore epigenetics to make new therapies or make existing therapies work better
Confused about cancer? 1.800.4.CANCER is here to help
The taxpayer-supported National Cancer Institute contact center is based at Fred Hutch Cancer Center
How chronic graft-versus-host disease unfolds ten years after transplant
From the Lee Lab, Clinical Research Division
A group retreat model for psilocybin therapy in cancer care
From Dr. Anthony Back and the Gooley Group, Clinical Research Division
Fred Hutch hematologists featured at 2026 Tandem Meetings
Researchers highlight findings on making stem cell transplants safer and more effective
Assessing HER2 expression in metastatic prostate and urothelial cancers
From Dr. Raychaudhuri, Dr. Haffner and colleagues, Clinical Research Division
Overcoming immune evasion: a new combination therapy advances treatment for a rare metastatic eye cancer
From Dr. Shailender Bhatia, Dr. Natalie Miller and colleagues, Clinical Research Division